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ABSTRACT
Objective: To translate the Understanding COPD (UCOPD) questionnaire into Portuguese, 
adapt it for use in Brazil, and assess its reliability. Methods: The UCOPD questionnaire 
consists of two sections, designated section A and section B. Section A comprises 18 
items divided into three domains: “About COPD”, “Managing Symptoms of COPD”, 
and “Accessing Help and Support”. Section B includes ﬁ ve questions regarding patient 
satisfaction with the educational component of pulmonary rehabilitation programs. The 
UCOPD questionnaire was applied twice on the same day by two different raters (with a 
10-min interval between applications) and once again 15-20 days later. The Wilcoxon test 
was used in order to compare the scores among applications. Reliability was assessed by 
the intraclass correlation coefﬁ cient and Bland-Altman plots. Results: The study sample 
consisted of 50 COPD patients (35 men; mean age, 65.3 ± 7.91 years; mean FEV1, 36.4 
± 16.2% of the predicted value). Inter-rater intraclass correlation coefﬁ cients for section 
A total scores and domain scores ranged from moderate to high. Section A scores and 
domain scores had no signiﬁ cant differences regarding test-retest reliability (p < 0.05). 
The test-retest and inter-rater Cronbach’s alpha coefﬁ cients for section A total scores 
were 0.93 and 0.86, respectively (p < 0.001). There were no ﬂ oor or ceiling effects. 
Conclusions: The Brazilian Portuguese version of the UCOPD questionnaire is reliable. 
Keywords: Pulmonary disease, chronic obstructive; reproducibility of results; Health 
knowledge, attitudes, practice. 
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INTRODUCTION
Education is one of the key components of pulmonary 
rehabilitation programs (PRPs) for patients with COPD. In 
recent years, it has received greater attention because 
it can teach patients how to cope with their disease and 
because it can increase the likelihood of their adopting 
self-management strategies.(1)
Education involves activities that encourage patients and 
their families to learn more about and, consequently, gain 
a deeper understanding of the disease, thus improving 
patient self-efﬁ cacy.(1,2) Education plays an important 
role in promoting behavioral changes,(2,3) which are 
necessary because patients may not actively engage in 
appropriate behaviors which could improve their health 
outcomes.(4) This might be due to a lack of understanding 
of the importance of appropriate behavior or to a lack of 
disease-related self-efﬁ cacy. Educational interventions 
can change these outcomes and have proved to be 
effective in patients with COPD, being associated with 
improvement in self-management skills,(2) i.e., improved 
medication use, increased ability to manage disease 
exacerbations, and increased ability to achieve disease 
management goals.(5) However, despite its importance, 
education is seldom evaluated in PRPs because there 
are only a few instruments available for this purpose. 
The Understanding COPD (UCOPD) questionnaire,(4) the 
Bristol COPD Knowledge Questionnaire (BCKQ),(6) the 
Lung Information Needs Questionnaire (LINQ),(7) and 
the Mount Sinai Hospital Questionnaire(8) have been 
developed to assess patient knowledge of COPD. The 
UCOPD questionnaire stands out because, in addition to 
evaluating patient understanding of COPD, it assesses 
self-efﬁ cacy, use of self-management skills, and patient 
satisfaction with a given PRP.(4) However, there is 
currently no Brazilian Portuguese version of the UCOPD 
questionnaire. Therefore, given the importance of an 
instrument that can evaluate the effect of the educational 
component of PRPs, the objective of the present study 
was to translate the UCOPD questionnaire into Brazilian 
Portuguese and determine the reliability of the Brazilian 
Portuguese version of the questionnaire.
METHODS
Fifty patients with COPD referred to the Núcleo de 
Assistência, Ensino e Pesquisa em Reabilitação Pulmonar of 
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the Universidade do Estado de Santa Catarina, located 
in the city of Florianópolis, Brazil, were included in the 
study. The inclusion criteria were as follows: having 
a clinical diagnosis of COPD conﬁ rmed by spirometry 
in accordance with the Global Initiative for Chronic 
Obstructive Lung Disease (GOLD) criteria(9) and self-
reporting the ability to read in Brazilian Portuguese.
Patients unable to understand the questionnaire or 
to follow instructions were excluded (a Mini-Mental 
State Examination score of 18/19 for patients without 
previous formal education and a score of 24/25 
for patients with previous formal education).(10) In 
addition, patients with any other severe or limiting 
respiratory or nonrespiratory disease were excluded. 
The local research ethics committee approved the 
study (CAAE protocol no. 11603112.1.0000.0118), 
and all participants gave written informed consent. 
The relevant measurement properties of the UCOPD 
questionnaire were evaluated in accordance with the 
recommendations of the Consensus-based Standards 
for the Selection of Health Status Measurement 
Instruments.(11) The authors of the original version 
authorized the cross-cultural adaptation of the UCOPD 
questionnaire.
The cross-cultural adaptation protocol was as 
recommended by Guillemin et al.(12) First, the English 
version of the UCOPD questionnaire(4) was translated 
into Brazilian Portuguese by two independent bilingual 
translators who are ﬂ uent in English and native speakers 
of Brazilian Portuguese, one of whom had no speciﬁ c 
knowledge of health. A summary of the translations was 
made by a translation review committee, comprising 
the ﬁ rst author of the original questionnaire, the 
translators, and health professionals. That version was 
subsequently back-translated by a health professional 
who is a native speaker of English and ﬂ uent in 
Portuguese. The back-translator had previously had 
no contact with the questionnaire.
That ﬁ rst version was applied to 8 patients with 
COPD in order to identify uncertainties and difﬁ culties 
regarding the text. Afterwards, issues raised by those 
patients were discussed by the review committee, and 
a consensus was reached. The ﬁ nal version of the 
instrument did not require cross-cultural adaptations 
or changes in the original structure. Although the name 
of the questionnaire was translated into Portuguese, 
a decision was made to keep the original, English-
language abbreviation of the name (i.e., UCOPD) in the 
Brazilian Portuguese version of the questionnaire so as 
to facilitate recognition of the instrument. Appendix 1 
(http://jornaldepneumologia.com.br/detalhe_anexo.
asp?id=56) shows the ﬁ nal version of the translated 
questionnaire.
The Brazilian Portuguese version of the UCOPD 
questionnaire was tested for inter-rater and test-retest 
reliability. On the ﬁ rst day, the questionnaire was applied 
twice by two raters (R1 and R2) in the following order: 
ﬁ rst by R1 and 10 min later by R2. After 15-20 days, 
it was reapplied by R2.(13)
The UCOPD questionnaire(4) consists of two sections: 
section A has 18 items in three domains: “About COPD”, 
“Managing Symptoms of COPD”, and “Accessing Help 
and Support”; section B has ﬁ ve questions regarding 
patient satisfaction with the educational component of 
the PRP. The answers to each question are indicated 
on a ten-centimeter visual analog scale with numerical 
intervals per centimeter.
The scores for the domains and the total score for 
section A range from 0% to 100%. The higher the 
score, the better the understanding, self-efﬁ cacy, 
medication use, and satisfaction. To calculate the 
scores for each domain, the scores for the individual 
questions in the domain are added up, divided by the 
maximum score for the domain, and multiplied by 100. 
The maximum scores for the domains, as well as total 
scores for sections A and B, are as follows: About COPD 
domain (questions 1-7), 70; Managing Symptoms of 
COPD domain (questions 8-14), 70; Accessing Help 
and Support domain (questions 15-18), 40; section A 
total score (questions 1-18), 180; and section B total 
score (questions 1-5), 50.(4)
For sample characterization, participants underwent 
spirometry (EasyOne® spirometer; ndd Medical 
Technologies, Zurich, Switzerland) in accordance with 
the American Thoracic Society/European Respiratory 
Society standards.(14) The predicted values were 
obtained from the equations proposed by Pereira et 
al.(15) The spirometric and multidimensional GOLD 
classiﬁ cations(9) were used in order to stratify the 
severity of COPD. The Brazilian Portuguese versions of 
the Saint George’s Respiratory Questionnaire (SGRQ)(16)  
and the COPD Assessment Test (CAT)(17) were applied 
to all participants, who were also evaluated regarding 
their physical activity in daily life (PADL) for 12 h on 
two consecutive week days.(18)
Data are presented as mean ± standard deviation and 
95% conﬁ dence interval. We used the Wilcoxon test to 
compare the scores of the UCOPD questionnaire between 
the applications. The mixed two-way, single-measure 
intraclass correlation coefﬁ cient (ICC) and respective 
95% CIs were used in order to analyze the reliability 
of UCOPD questionnaire, whereas the Cronbach’s 
alpha coefﬁ cient was used to analyze the internal 
consistency of the questionnaire. The classiﬁ cation 
used for the ICC was as follows: low reproducibility, 
ICC < 0.40; moderate reproducibility, ICC ≤ 0.75; 
and high reproducibility, ICC > 0.75.(19)
Bland-Altman plots were used in order to represent 
the agreement between the UCOPD questionnaire 
scores, whereas the Spearman’s correlation coefﬁ cient 
was used in order to assess the correlation of UCOPD 
questionnaire scores with SGRQ and CAT scores, as 
well as with the level of PADL. The standard error of 
measurement and the minimum detectable difference 
(MDD) were calculated as described by Terwee et al.(20) 
For the analysis of the ﬂ oor and ceiling effects, the 
proportions of occurrence of the minimum (0%) and 
maximum (100%) scores for section A of the UCOPD 
questionnaire were used.(20) The signiﬁ cance level 
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was 5%. Data analysis was performed with the IBM 
SPSS Statistics software package, version 20.0 (IBM 
Corporation, Armonk, NY, USA), and graphics were 
created using the GraphPad Prism program, version 
5.0 (GraphPad Inc., San Diego, CA, USA). In order 
to estimate the sample size, in accordance with the 
Consensus-based Standards for the Selection of Health 
Status Measurement Instruments(21)  recommendation, 
50 patients were selected (good sample size). Sample 
size calculation was also based on an expected ICC 
of 0.50 for moderate reliability,(19) α = 0.05, and β = 
0.10, yielding a sample size of 38 patients.(22)
RESULTS
Fifty-ﬁ ve patients with COPD were enrolled in the 
study. Of those, 2 were excluded for not completing the 
protocol and 3 because of disease exacerbation during 
the protocol. Therefore, 50 patients completed the 
protocol (35 males). Table 1 presents the characteristics 
of the patients.
The level of education varied among the patients: 
7 (14%) had completed college; 4 (8%) had not 
completed college; 17 (34%) had completed high 
school; 2 (4%) had not completed high school; 4 (8%) 
had completed elementary school; 15 (30%) had not 
completed elementary school; and 1 (2%) had never 
attended school.
There were no differences in test-retest reliability 
scores for section A total score and its domains. There 
were signiﬁ cant differences in About COPD domain 
scores between R1 and R2 (Table 2). Table 2 shows 
the scores for section A and its domains, as well as 
test-retest and inter-rater ICCs, which ranged from 
satisfactory to excellent. None of the patients scored 
0% or 100%.
In the agreement analysis, inter-rater Cronbach’s 
alpha coefﬁ cients for section A total score and its 
domains (About COPD, Managing Symptoms of COPD, 
and Accessing Help and Support) were 0.93, 0.94, 
0.83, and 0.94, respectively (p < 0.001 for all).
In 11 of the 18 items in section A, ICCs were higher 
than 0.75 (p < 0.001). Items 3, 7, 8, 9, 13, 14, and 
15 showed satisfactory reproducibility (an ICC of 
0.54-0.68; p < 0.001). Of those items, 4 belonged to 
the Managing Symptoms of COPD domain.
With regard to test-retest reliability, the Cronbach’s 
alpha coefﬁ cient for section A total score was 0.86 
(p < 0.001), and those for About COPD, Managing 
Symptoms of COPD, and Accessing Help and Support 
domain scores were 0.83, 0.76, and 0.87, respectively 
(p < 0.001). The ICCs were higher than 0.75 in 8 of 
the 18 items (p < 0.001). However, ICCs ranged from 
0.43 to 0.70 for items 3, 4, 7, 8, 9, 10, 12, 14, 15, and 
17. Five of the 7 items in the Managing Symptoms of 
COPD domain had ICCs lower than 0.75. The standard 
error of measurement was 6, and the MDD was 16.6.
Figure 1 shows the agreement between R1 and R2. 
There was a wide variability among UCOPD questionnaire 
applications, which was more pronounced in the test-
retest analysis (Figure 2).
UCOPD questionnaire domain scores correlated weakly 
with CAT and SGRQ scores, as well as with the level of 
PADL. UCOPD questionnaire section A scores correlated 
with the total SGRQ score (r = −0.38; p = 0.007) 
and SGRQ “impacts” domain scores (r = −0.46; p = 
0.001), as well as with sitting (r = −0.33; p = 0.024), 
standing (r = 0.33; p = 0.023), and walking times (r 
= 0.30; p = 0.04). UCOPD questionnaire About COPD 
domain scores correlated with the total SGRQ score 
(r = −0.30; p = 0.033) and SGRQ impacts domain 
scores (r = −0.35; p = 0.014), as well as with sitting 
time (r = −0.32; p = 0.027). UCOPD questionnaire 
Managing Symptoms of COPD domain scores correlated 
with SGRQ impacts domain scores (r = −0.35; p = 
0.014), whereas UCOPD questionnaire Accessing Help 
and Support domain scores correlated with the CAT 
score (r = −0.30; p = 0.042), the total SGRQ score (r 
= −0.42; p = 0.003), SGRQ “activity” domain scores 
(r = −0.33; p = 0.019), SGRQ impacts domain scores 
(r = −0.48; p = 0.013), sitting time (r = −0.38; p 
= 0.004), standing time (r = 0.42; p = 0.003), and 
walking time (r = 0.35; p = 0.013), as well as with a 
level of PADL ≥ 3 metabolic equivalents (r = 0.33; p 
= 0.021). No correlations were found between FEV1 
and the total UCOPD questionnaire score or between 
FEV1 and UCOPD questionnaire domain scores (values 
of p = 0.24-0.88).
DISCUSSION
The major ﬁ nding of the present study is that the 
UCOPD questionnaire is reliable and able to reﬂ ect 
Table 1. Characteristics of the COPD patients included in 
the present study (N = 50).a
Variable Result
Age, years 65.3 ± 7.91
BMI, kg/m2 25.5 ± 4.81
FEV1/FVC 0.45 ± 0.10
FVC, L 2.31 ± 0.73
FVC, % predicted 61.1 ± 18.0
FEV1, L 1.07 ± 0.48
FEV1, % predicted 36.4 ± 16.2
Mini-Mental State Examination score 27.3 ± 2.65
CAT 16.6 ± 7.79
GOLD, stages II-III-IV, n (%)
II 12 (24)
III 18 (36)
IV 20 (40)
GOLD, stages A-B-C-D, n (%)
A 02 (04)
B 10 (20)
C 06 (12)
D 32 (64)
 BMI: body mass index; CAT: COPD Assessment 
Test; and GOLD: Global Initiative for Chronic 
Obstructive Lung Disease.aValues expressed as 
mean ± SD, except where otherwise indicated.
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quality of life, health status, and PADL in patients 
with COPD in Brazil. The test-retest reliability and the 
inter-rater reliability of the total score for section A of 
the UCOPD questionnaire were excellent. The reliability 
of the domains ranged from satisfactory to excellent, 
the ICCs being lowest for the Managing Symptoms of 
COPD domain and the test-retest reliability analysis.
In the study of development and validation of the 
UCOPD questionnaire,(4) the authors found excellent 
reliability of the domains and section A total score. 
Interestingly, the Managing Symptoms of COPD domain 
had the highest ICC among the UCOPD questionnaire 
domains (ICC = 0.92; 95% CI: 0.81-0.97). Some factors 
can explain why the results of the present study differed 
from the aforementioned results. O’Neill et al.(4) included 
only patients who had a good understanding of written 
English, and the questionnaire was self-administered. 
Given that most of the elderly individuals in Brazil have 
low levels of education,(23) the UCOPD questionnaire was 
completed by interviewing the participants. Although 
this is permitted according to the UCOPD questionnaire 
application instructions, the low education level of the 
Table 2. Scores, test-retest intraclass correlation coefﬁ cients, and inter-rater intraclass correlation coefﬁ cients for the 
Understanding COPD questionnaire (section A total score and domain scores).a
Section A total score and domain scores Rater 1 Rater 2 test Rater 2 retest
About COPD (%) 66.1 ± 18.9 71.0 ± 19.5 72.8 ± 18.9*
Managing Symptoms of COPD (%) 67.0 ± 19.0 63.4 ± 20.1 67.3 ± 18.1
Accessing Help and Support (%) 65.2 ± 28.9 64.9 ± 30.3 69.2 ± 27.8
Section A, total (%) 62.3 ± 16.1 62.9 ± 18.4 66.0 ± 16.4
Section A total score and domain scores Inter-rater ICC (95% CI) Test-retest ICC (95% CI)
About COPD 0.85 (0.70-0.92) 0.72 (0.56-0.83)
Managing Symptoms of COPD 0.70 (0.53-0.82) 0.61 (0.41-0.76)
Accessing Help and Support 0.89 (0.81-0.93) 0.77 (0.63-0.86)
Section A, total 0.88 (0.79-0.93) 0.74 (0.59-0.88)
ICC: intraclass correlation coefﬁ cient. aValues expressed as mean ± SD, except where otherwise indicated. *p < 
0.05 vs. rater 1.
Figure 1. Bland-Altman plots for inter-rater reliability. In A, section A total score; in B, “About COPD” domain scores; 
in C, “Managing Symptoms of COPD” domain scores; and in D, “Accessing Help and Support” domain scores.
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majority of the study participants (32% of whom had 
not completed elementary school) could have affected 
patient understanding of the Managing Symptoms of 
COPD domain items and, consequently, contributed 
to reducing its reliability. However, it was decided not 
to exclude those patients from the sample. Had they 
been excluded, the sample would no longer have been 
representative of the Brazilian population, the external 
validity of the instrument therefore being compromised.
The reliability of section B of the UCOPD questionnaire 
was not analyzed in the present study or in the original 
study.(4) Section B of the UCOPD questionnaire has 
been reported to have high internal consistency and 
concordance.(4) In the present study, section B was 
administered to 7 patients, all of whom had completed 
a PRP, and the answers were the same for all items. It is 
worth mentioning that section B is aimed at evaluating 
patient satisfaction with the education sessions; it is 
not part of the evaluation of patient knowledge and 
self-efﬁ cacy.
Given the lack of a previously validated instrument to 
assess knowledge and self-efﬁ cacy in COPD patients in 
Brazil, it was impossible to test the concurrent validity 
of the UCOPD questionnaire. A correlation of 0.303 (p = 
0.002) has been obtained between the English-language 
version of the UCOPD questionnaire and the BCKQ.(4) 
The association with other outcomes, however, has 
yet to be tested. Despite weak correlations, it appears 
that patients with limited knowledge of COPD have 
impaired quality of life, increased sitting time, and 
reduced time spent in active postures (walking and 
standing). It appears that the more patients know 
about their disease and the more conﬁ dent they feel 
about how much they know about it, the more active 
they become and the better their quality of life is. 
However, this has yet to be conﬁ rmed. Nevertheless, 
this reinforces the hypothesis that increasing patient 
knowledge and self-efﬁ cacy is an important strategy 
to promote long-term adherence to active and healthy 
behaviors.(1,24,25) In addition, this suggests that the 
UCOPD questionnaire is capable of reﬂ ecting other 
important outcomes, reinforcing its validity.
Although the educational component of PRPs is 
currently focused on promoting knowledge, self-care, 
and self-management, as well on increasing self-efﬁ cacy, 
there are only a few instruments that can be used in 
order to evaluate some or all of these outcomes: the 
UCOPD questionnaire, the BCKQ,(6) and the LINQ.(7) 
These instruments were developed in England and 
are reliable and valid; they can be used in order to 
assess patient response to educational programs(6) 
and PRPs.(26) However, to the best of our knowledge, 
there are currently no data regarding the translation 
and cross-cultural adaptation of these instruments 
Figure 2. Bland-Altman plots for test-retest reliability. In A, section A total score; in B, “About COPD” domain scores; 
in C, “Managing Symptoms of COPD” domain scores; and in D, “Accessing Help and Support” domain scores.
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in Brazil. In addition, neither the BCKQ nor the LINQ 
address patient self-efﬁ cacy; they are used in order to 
assess patient knowledge. In contrast, in addition to 
assessing patient knowledge, the UCOPD questionnaire 
assesses patient self-efﬁ cacy and patient satisfaction 
with the educational component of PRPs.(4)
Self-efﬁ cacy is now regarded as one of the major 
outcomes to be assessed in patients participating in a 
PRP, because it appears to be associated with adoption 
and maintenance of active and healthy behaviors.(1) 
It is deﬁ ned as the conﬁ dence that an individual has 
in their ability to deal with a speciﬁ c task,(3) such as 
successfully managing their disease. Unlike the BCKQ 
or the LINQ, the UCOPD questionnaire addresses how 
conﬁ dent patients are that they know what COPD is; 
that they can recognize an exacerbation; that they 
know when to seek medical attention; that they know 
how to use their COPD medication; and that they know 
how to exercise, among other questions. Therefore, it 
is an interesting tool that can aid in the identiﬁ cation 
and development of strategies for patients who, 
despite having good knowledge of their disease, are 
not conﬁ dent about applying what they know or being 
able to manage their health, a lack of conﬁ dence that 
might result in nonadherence to treatment.
Despite cultural differences between Brazil and 
Northern Ireland, the Brazilian Portuguese version of the 
UCOPD questionnaire required no major adjustments. 
The ﬁ nal version of the questionnaire is the same as 
the ﬁ rst translated version, and its back-translation 
was approved by the ﬁ rst author of the original 
questionnaire. The Brazilian Portuguese version of the 
UCOPD questionnaire was found to be reliable, having 
no ﬂ oor or ceiling effect. This ﬁ nding is important 
because a ﬂ oor/ceiling effect could compromise the 
discriminatory ability of the questionnaire or the 
detection of change over time/after an intervention.(20)
One potential limitation of the present study is the 
time elapsed between the two applications of the 
questionnaire (i.e., 10 min for inter-rater reliability 
analysis and 15-20 days for test-retest reliability 
analysis). Although one of the assumptions of the 
reliability test procedure is that the interval between 
applications should be short but long enough to avoid 
respondent memory bias,(27) we found no speciﬁ c 
recommendations regarding how long that interval 
should be. Although the results of the present study 
were satisfactory, our interval between applications 
was longer than that in the original study. Therefore, 
it is possible that patient clinical status changed during 
that time interval, patient responses being inﬂ uenced 
by that. Another possible limitation is that we did not 
test the responsiveness of the Brazilian Portuguese 
version of the UCOPD questionnaire to a PRP or other 
interventions. In addition, there are currently no data 
such as cut-off points and minimal clinically important 
difference to assist in interpreting the results of the 
UCOPD questionnaire. However, this was outside the 
scope of the present study, further studies therefore 
being required. Our ﬁ nding of an MDD of 16.6 reﬂ ects 
the lowest intrapersonal variation; therefore, changes 
above this point showing a value of p < 0.05 can be 
considered “real”.(20)
To the best of our knowledge, this is the ﬁ rst study 
designed to develop a Brazilian Portuguese version of the 
UCOPD questionnaire, which is a reliable questionnaire 
to assess patient knowledge of COPD and patient 
self-efﬁ cacy in managing the disease. Our ﬁ ndings 
can inform clinical practice, allowing the evaluation 
of the aforementioned outcomes and contributing to 
the development of strategies to improve them. In 
addition, they allow the evaluation of the results of 
educational programs.
In summary, when translating an outcome measure 
tool for use in a different country, it is important to 
ensure that the properties remain robust. The present 
study demonstrated that the Brazilian Portuguese 
version of the UCOPD questionnaire is reliable, has 
internal consistency, and has no ﬂ oor or ceiling effects 
that might hinder its use in COPD patients in Brazil. 
In addition, the questionnaire is able to reﬂ ect health 
status, quality of life, and PADL in such patients. Further 
studies are needed in order to determine whether the 
Brazilian Portuguese version of the UCOPD questionnaire 
is responsive to PRPs.
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